Federal court ‘vacates in its entirety’ the FDA’s costly, onerous lab test rule
A federal district court has struck a blow for medical innovation and patient empowerment by overruling the Food and Drug Administration's (FDA) misbegotten effort to regulate laboratory-developed (LDTs) and in vitro…
